Title : Synergy between all-trans retinoic acid and tumor necrosis factor pathways in acute leukemia cells.

Pub. Date : 2003 Jul 1

PMID : 12586626






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Here we show that TNF can synergize with ATRA to induce differentiation, showing monocytic characteristics more typical of differentiation mediated by TNF than by ATRA. Tretinoin tumor necrosis factor Homo sapiens
2 Here we show that TNF can synergize with ATRA to induce differentiation, showing monocytic characteristics more typical of differentiation mediated by TNF than by ATRA. Tretinoin tumor necrosis factor Homo sapiens
3 Underlying this response was an increase in TNF-induced nuclear factor-kappaB (NF-kappaB) DNA binding within 2 hours in the presence of ATRA and activation of NF-kappaB DNA binding and transcriptional activity in response to ATRA alone within 48 hours of ATRA treatment. Tretinoin tumor necrosis factor Homo sapiens
4 Underlying this response was an increase in TNF-induced nuclear factor-kappaB (NF-kappaB) DNA binding within 2 hours in the presence of ATRA and activation of NF-kappaB DNA binding and transcriptional activity in response to ATRA alone within 48 hours of ATRA treatment. Tretinoin tumor necrosis factor Homo sapiens
5 Underlying this response was an increase in TNF-induced nuclear factor-kappaB (NF-kappaB) DNA binding within 2 hours in the presence of ATRA and activation of NF-kappaB DNA binding and transcriptional activity in response to ATRA alone within 48 hours of ATRA treatment. Tretinoin tumor necrosis factor Homo sapiens
6 We propose that ATRA can prime cancer cells for differentiation triggered by TNF and suggest that targeting the TNF pathway in combination with ATRA may represent a novel route to treat leukemias. Tretinoin tumor necrosis factor Homo sapiens
7 We propose that ATRA can prime cancer cells for differentiation triggered by TNF and suggest that targeting the TNF pathway in combination with ATRA may represent a novel route to treat leukemias. Tretinoin tumor necrosis factor Homo sapiens